CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial)

NCT06242418 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: FOLFOXIRI
DRUG: XELOX

Sponsor

West China Hospital

Collaborators

[object Object]